[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

DelveInsight: Market Research Reports

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:

  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.


This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.

Publications found: 6,889
Sort by:

C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “C-Met Mutated Non-small Cell Lung Cancer (NSCLC) - Pipeline Insight, 2021,” report provides comprehensive insights abo...

February 2021 60 pages

CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2021,” report provides comprehensive insights...

February 2021 60 pages

CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ com...

February 2021 60 pages

CAR T-Cell Therapy for Non-Hodgkin’s lymphoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about...

February 2021 60 pages

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2021,” report provides comprehensive insights about...

February 2021 60 pages

Chronic Otitis Media (COM) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Otitis Media (COM) - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+...

February 2021 60 pages

Chronic Pulmonary Infections - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Pulmonary Infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...

February 2021 60 pages

Chronic Traumatic Encephalopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Chronic Traumatic Encephalopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies...

February 2021 60 pages

Complicated skin and soft tissue infections (cSSTI) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Complicated skin and soft tissue infections (cSSTI) - Pipeline Insight, 2021,” report provides comprehensive insights...

February 2021 60 pages

Diabetic Cardiomyopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Cardiomyopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pi...

February 2021 60 pages

Diabetic Ketoacidosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Diabetic Ketoacidosis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipe...

February 2021 60 pages

Egg allergy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Egg allergy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...

February 2021 60 pages

Endocarditis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Endocarditis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drug...

February 2021 60 pages

ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “ER+/ HER2 -ve Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...

February 2021 60 pages

Excessive Daytime Sleepiness - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Excessive Daytime Sleepiness - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...

February 2021 60 pages

Familial Mediterranean Fever - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Familial Mediterranean Fever - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...

February 2021 60 pages

Gout - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Gout - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gou...

February 2021 60 pages

Hedgehog Pathway Inhibitors - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hedgehog Pathway Inhibitors - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...

February 2021 60 pages

Hodgkin’s Lymphoma – Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Hodgkin’s Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...

February 2021 60 pages

Human Immunodeficiency Virus (HIV 1) Infection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Human Immunodeficiency Virus Type 1 (HIV-1) Infection – Pipeline Insight, 2021,” report provides comprehensive insight...

February 2021 60 pages

Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Human papillomavirus 16-positive (HPV16+) cancers - Pipeline Insight, 2021,” report provides comprehensive insights ab...

February 2021 60 pages

Inflammatory Pain - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inflammatory Pain - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...

February 2021 60 pages

Inter Alpha Inhibitor Proteins - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Inter Alpha Inhibitor Proteins – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies an...

February 2021 60 pages

Lou Gehrig's Disease - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lou Gehrig's disease – Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pip...

February 2021 60 pages

Lymphatic Malformations - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Lymphatic Malformations– Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pip...

February 2021 60 pages

MELAS Sundrome- Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “MELAS Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline dr...

February 2021 60 pages

Metastatic Bone Pain- Pipeline insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Metastatic Bone pain – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pip...

February 2021 60 pages

Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2021,” report provides comprehensive insights abo...

February 2021 60 pages

Minimal Change Disease- Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Minimal Change Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pip...

February 2021 60 pages

Moderate and Severe Chronic Kidney Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Moderate and Severe Chronic Kidney Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 4+...

February 2021 60 pages

Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Moderate to Severe Atopic Dermatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ compan...

February 2021 60 pages

Molluscum Contagiosum - Pipeline Insight

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Molluscum Contagiosum - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pi...

February 2021 60 pages

Mucinous cystic neoplasm - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Mucinous cystic neoplasm - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...

February 2021 60 pages

Nasal Polyposis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Nasal Polyposis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline d...

February 2021 60 pages

Natural Killer T Cell Lymphoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Natural Killer T Cell Lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies an...

February 2021 60 pages

Necrobiosis Lipoidica - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrobiosis Lipoidica - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipe...

February 2021 60 pages

Necrotizing Enterocolitis – Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Necrotizing Enterocolitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...

February 2021 60 pages

Netherton Syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Netherton Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipelin...

February 2021 60 pages

Niemann Pick C Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Niemann Pick C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...

February 2021 60 pages

Opioid Withdrawal Syndrome-Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Opioid withdrawal syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+...

February 2021 60 pages

Palmoplantar Keratoderma- Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Keratoderma – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ p...

February 2021 60 pages

Palmoplantar Pustulosis- Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Palmoplantar Pustulosis – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pi...

February 2021 60 pages

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pediatric Growth Hormone Deficiency - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ compani...

February 2021 60 pages

Pericarditis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pericarditis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drug...

February 2021 60 pages

Pneumococcal Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pneumococcal Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipel...

February 2021 60 pages

Polypoidal choroidal vasculopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Polypoidal choroidal vasculopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies...

February 2021 60 pages

Pre-Eclampsia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pre-Eclampsia – Pipeline Insight, 2021,” report provides comprehensive insights about companies and pipeline drugs in...

February 2021 60 pages

Pseudomonas aeruginosa infection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pseudomonas aeruginosa infection - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies...

February 2021 60 pages

Rabies virus - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Rabies virus - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline dr...

February 2021 60 pages

Radiodermatitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Radiodermatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...

February 2021 60 pages

Filters

Search

Categories

5,477
618
651
143

Publishers

6,889

Regions

6,889

Price

Date

Pages

Offers